Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome Full Text
Journal of Clinical Oncology,  Clinical Article

List AF et al. – Deferasirox reduces serum ferritin and Labile plasma iron (LPI) in transfusion–dependent patients with MDS. A subset of patients had an improvement in hematologic and hepatic parameters.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore